KESHAV K SINGH
Dr. Singh is one of the world leaders in the field of mitochondrial determinants of health, disease, diversity, health disparities and personalized medicine. Currently, he is the Joy and Bill Harbert Endowed Chair and Director of Cancer Genetics at the University of Alabama at Birmingham. He is also a Professor of Genetics, Pathology and Environmental Health. Besides a mitochondrial role in health and disease, he is an expert in mitochondrial genetics, numtogenesis, cancer genetics, and cancer health disparities. He is the founding editor-in-chief of the Mitochondrion journal as well as Cancer Health Disparities. Dr. Singh has been cited in newspapers, magazine, and has given interviews to radio shows and television about stories of public interest. His research has been highlighted in Nature, Newsweek, US News and World Report, Forbes, Vogue, Bazaar, Beauty Crew, Hindustan Times, International Business Times, Bloomberg and many other news outlets around the world. Dr. Singh founded the Mitochondria Research and Medicine Society in the US and India and is instrumental in promoting understanding and awareness of the mitochondrial diseases around the globe. He has organized numerous scientific meetings and workshops on mitochondria related topics. He has also given many keynote lectures and chaired or co-chaired scientific sessions in national and international professional meetings. Dr. Singh has served or serves on the editorial board of many journals. He is the author of more than a hundred research publications and three books. He has served or serves on expert grants review panels in the United States, Austria, Italy, UK, Poland, Singapore, and other countries. He has won numerous awards. Dr. Singh did his undergraduate degree in India, Ph.D. in Australia and the postdoctoral studies at Harvard, USA. After completing his postdoctoral studies, he joined John Hopkins as Assistant Professor of Oncology at Johns Hopkins School of Medicine. Prior to moving to University of Alabama at Birmingham (UAB), he was at Roswell Park Cancer Institute in Buffalo NY where he rose through the ranks to Professor and then to Distinguish Professor of Oncology.